MHRA-102528-PIP01-26

Key Facts

Active Substance
Active Substance:
  • Humanised IgG1 monoclonal antibody against microtubule-associated protein tau MK-2214
Invented Name
Not yet available
PIP Number MHRA-102528-PIP01-26
Pharmaceutical form(s)
  • Solution for injection
  • Solution for infusion
Therapeutic area
Therapeutic area:
  • Neurology
Conditions / Indications
Conditions / Indications:
  • Treatment of Alzheimer's disease
Route(s) of administration
  • intravenous
  • Subcutaneous use
PIP applicant
Decision Type
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Humanised IgG1 monoclonal antibody against microtubule-associated protein tauMK-2214.pdf
Published Date 20/10/2026